These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31678928)

  • 1. An unusual bullous eruption: olanzapine induced pseudoporphyria.
    Johnson OR; Stewart MF; Bakshi A; Weston P
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-induced and Risperidone-induced Leukopenia: A Case of Synergistic Adverse Reaction?
    Woon LS; Tee CK; Gan LLY; Deang KT; Chan LF
    J Psychiatr Pract; 2018 Mar; 24(2):121-124. PubMed ID: 29509183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flutamide-induced late cutaneous pseudoporphyria].
    Mantoux F; Bahadoran P; Perrin C; Bermon C; Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 1999 Feb; 126(2):150-2. PubMed ID: 10352831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis.
    Breier F; Feldmann R; Pelzl M; Gschnait F
    Dermatology; 1998; 197(3):271-3. PubMed ID: 9812036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory-induced pseudoporphyria: is there an alternative drug?
    Checketts SR; Morrison KA; Baughman RD
    Cutis; 1999 Apr; 63(4):223-5. PubMed ID: 10228751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine.
    Mustafa FA; Nayar A
    Psychopharmacol Bull; 2019 Jun; 49(2):63-64. PubMed ID: 31308585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
    Þorsteinsdóttir S; Velander MJ; Bygum A
    Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoporphyria induced by propionic acid derivatives.
    Al-Khenaizan S; Schechter JF; Sasseville D
    J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Olanzapine-Induced Fever.
    Yang CH; Chen YY
    Psychopharmacol Bull; 2017 Jan; 47(1):45-47. PubMed ID: 28138204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance.
    Li H; Peng S; Li S; Liu S; Lv Y; Yang N; Yu L; Deng YH; Zhang Z; Fang M; Huo Y; Chen Y; Sun T; Li W
    Sci Rep; 2019 Feb; 9(1):1582. PubMed ID: 30733507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria.
    de Groot HJ; Jonkman MF; Pas HH; Diercks GFH
    Acta Derm Venereol; 2019 Jan; 99(1):26-32. PubMed ID: 30176039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders.
    Kraal AZ; Ward KM; Ellingrod VL
    Psychopharmacol Bull; 2017 May; 47(2):8-21. PubMed ID: 28626268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furosemide-induced pseudoporphyria in a patient with chronic kidney disease: case report.
    Pavanelli GM; Milano SS; Sevignani G; Jung JE; Funke VAM; Nascimento MMD
    J Bras Nefrol; 2018; 40(3):287-290. PubMed ID: 30010691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoporphyria: an atypical variant resembling toxic epidermal necrolysis.
    Papadopoulos AJ; Schwartz RA; Fekete Z; Kihiczak G; Samady JA; Atkin SH; Lambert WC
    J Cutan Med Surg; 2001; 5(6):479-85. PubMed ID: 11907856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
    Schmidt-Kraepelin C; Feyerabend S; Engelke C; Riesbeck M; Meisenzahl-Lechner E; Gaebel W; Verde PE; Kolbe H; Correll CU; Leucht S; Heres S; Kluge M; Makiol C; Neff A; Lange C; Englisch S; Zink M; Langguth B; Poeppl T; Reske D; Gouzoulis-Mayfrank E; Gründer G; Hasan A; Brockhaus-Dumke A; Jäger M; Baumgärtner J; Wobrock T; Cordes J
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):83-94. PubMed ID: 31486890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Onset Postinjection Delirium/Sedation Syndrome Associated With Olanzapine Pamoate: A Case Report.
    Garg S; Gupta D; Rakesh K; Tikka SK
    J Clin Psychopharmacol; 2019; 39(5):523-524. PubMed ID: 31433337
    [No Abstract]   [Full Text] [Related]  

  • 19. A Randomized, 8-Week Study of the Effects of Extended-Release Paliperidone and Olanzapine on Heart Rate Variability in Patients With Schizophrenia.
    Pu ZP; Li GR; Zou ZP; Tao F; Hu SH
    J Clin Psychopharmacol; 2019; 39(3):243-248. PubMed ID: 30925499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Solarium-induced pseudoporphyria and variegate porphyria as rare differential diagnoses of porphyria cutanea tarda].
    Kochs C; Mühlenstädt E; Neumann NJ; Hanneken S
    Hautarzt; 2009 Oct; 60(10):790-3. PubMed ID: 19756434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.